Radioembolization microspheres are a medical method that combines radiotherapy with embolization and is mainly used to treat liver malignant tumors.
The global Radioembolization Microsphere market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Radioembolization Microsphere is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Radioembolization Microsphere is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Radioembolization Microsphere include Boston Scientific, Quirem Medical, ABK Biomedical and Chengdu New Radiomedicine Technology Co.,Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Radioembolization Microsphere, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radioembolization Microsphere.
Report Scope
The Radioembolization Microsphere market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Radioembolization Microsphere market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radioembolization Microsphere manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Boston Scientific
Quirem Medical
ABK Biomedical
Chengdu New Radiomedicine Technology Co.,Ltd.
Segment by Type
Holmium 166 Microspheres
Yttrium 90 Microspheres
Others
Segment by Application
Liver Tumors
Liver Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Radioembolization Microsphere manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Radioembolization Microsphere in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Radioembolization Microsphere 麻豆原创 Overview
1.1 Product Overview and Scope of Radioembolization Microsphere
1.2 Radioembolization Microsphere Segment by Type
1.2.1 Global Radioembolization Microsphere 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Holmium 166 Microspheres
1.2.3 Yttrium 90 Microspheres
1.2.4 Others
1.3 Radioembolization Microsphere Segment by Application
1.3.1 Global Radioembolization Microsphere 麻豆原创 Value by Application: (2024-2030)
1.3.2 Liver Tumors
1.3.3 Liver Cancer
1.3.4 Others
1.4 Global Radioembolization Microsphere 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Radioembolization Microsphere Revenue 2019-2030
1.4.2 Global Radioembolization Microsphere Sales 2019-2030
1.4.3 Global Radioembolization Microsphere 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Radioembolization Microsphere 麻豆原创 Competition by Manufacturers
2.1 Global Radioembolization Microsphere Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Radioembolization Microsphere Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Radioembolization Microsphere Average Price by Manufacturers (2019-2024)
2.4 Global Radioembolization Microsphere Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Radioembolization Microsphere, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Radioembolization Microsphere, Product Type & Application
2.7 Radioembolization Microsphere 麻豆原创 Competitive Situation and Trends
2.7.1 Radioembolization Microsphere 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Radioembolization Microsphere Players 麻豆原创 Share by Revenue
2.7.3 Global Radioembolization Microsphere 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Radioembolization Microsphere Retrospective 麻豆原创 Scenario by Region
3.1 Global Radioembolization Microsphere 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Radioembolization Microsphere Global Radioembolization Microsphere Sales by Region: 2019-2030
3.2.1 Global Radioembolization Microsphere Sales by Region: 2019-2024
3.2.2 Global Radioembolization Microsphere Sales by Region: 2025-2030
3.3 Global Radioembolization Microsphere Global Radioembolization Microsphere Revenue by Region: 2019-2030
3.3.1 Global Radioembolization Microsphere Revenue by Region: 2019-2024
3.3.2 Global Radioembolization Microsphere Revenue by Region: 2025-2030
3.4 North America Radioembolization Microsphere 麻豆原创 Facts & Figures by Country
3.4.1 North America Radioembolization Microsphere 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Radioembolization Microsphere Sales by Country (2019-2030)
3.4.3 North America Radioembolization Microsphere Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Radioembolization Microsphere 麻豆原创 Facts & Figures by Country
3.5.1 Europe Radioembolization Microsphere 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Radioembolization Microsphere Sales by Country (2019-2030)
3.5.3 Europe Radioembolization Microsphere Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Radioembolization Microsphere 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Radioembolization Microsphere 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Radioembolization Microsphere Sales by Country (2019-2030)
3.6.3 Asia Pacific Radioembolization Microsphere Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Radioembolization Microsphere 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Radioembolization Microsphere 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Radioembolization Microsphere Sales by Country (2019-2030)
3.7.3 Latin America Radioembolization Microsphere Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Radioembolization Microsphere 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Radioembolization Microsphere 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Radioembolization Microsphere Sales by Country (2019-2030)
3.8.3 Middle East and Africa Radioembolization Microsphere Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Radioembolization Microsphere Sales by Type (2019-2030)
4.1.1 Global Radioembolization Microsphere Sales by Type (2019-2024)
4.1.2 Global Radioembolization Microsphere Sales by Type (2025-2030)
4.1.3 Global Radioembolization Microsphere Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Radioembolization Microsphere Revenue by Type (2019-2030)
4.2.1 Global Radioembolization Microsphere Revenue by Type (2019-2024)
4.2.2 Global Radioembolization Microsphere Revenue by Type (2025-2030)
4.2.3 Global Radioembolization Microsphere Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Radioembolization Microsphere Price by Type (2019-2030)
5 Segment by Application
5.1 Global Radioembolization Microsphere Sales by Application (2019-2030)
5.1.1 Global Radioembolization Microsphere Sales by Application (2019-2024)
5.1.2 Global Radioembolization Microsphere Sales by Application (2025-2030)
5.1.3 Global Radioembolization Microsphere Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Radioembolization Microsphere Revenue by Application (2019-2030)
5.2.1 Global Radioembolization Microsphere Revenue by Application (2019-2024)
5.2.2 Global Radioembolization Microsphere Revenue by Application (2025-2030)
5.2.3 Global Radioembolization Microsphere Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Radioembolization Microsphere Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Corporation Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific Radioembolization Microsphere Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boston Scientific Radioembolization Microsphere Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Quirem Medical
6.2.1 Quirem Medical Corporation Information
6.2.2 Quirem Medical Description and Business Overview
6.2.3 Quirem Medical Radioembolization Microsphere Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Quirem Medical Radioembolization Microsphere Product Portfolio
6.2.5 Quirem Medical Recent Developments/Updates
6.3 ABK Biomedical
6.3.1 ABK Biomedical Corporation Information
6.3.2 ABK Biomedical Description and Business Overview
6.3.3 ABK Biomedical Radioembolization Microsphere Sales, Revenue and Gross Margin (2019-2024)
6.3.4 ABK Biomedical Radioembolization Microsphere Product Portfolio
6.3.5 ABK Biomedical Recent Developments/Updates
6.4 Chengdu New Radiomedicine Technology Co.,Ltd.
6.4.1 Chengdu New Radiomedicine Technology Co.,Ltd. Corporation Information
6.4.2 Chengdu New Radiomedicine Technology Co.,Ltd. Description and Business Overview
6.4.3 Chengdu New Radiomedicine Technology Co.,Ltd. Radioembolization Microsphere Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chengdu New Radiomedicine Technology Co.,Ltd. Radioembolization Microsphere Product Portfolio
6.4.5 Chengdu New Radiomedicine Technology Co.,Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Radioembolization Microsphere Industry Chain Analysis
7.2 Radioembolization Microsphere Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Radioembolization Microsphere Production Mode & Process
7.4 Radioembolization Microsphere Sales and 麻豆原创ing
7.4.1 Radioembolization Microsphere Sales Channels
7.4.2 Radioembolization Microsphere Distributors
7.5 Radioembolization Microsphere Customers
8 Radioembolization Microsphere 麻豆原创 Dynamics
8.1 Radioembolization Microsphere Industry Trends
8.2 Radioembolization Microsphere 麻豆原创 Drivers
8.3 Radioembolization Microsphere 麻豆原创 Challenges
8.4 Radioembolization Microsphere 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Boston Scientific
Quirem Medical
ABK Biomedical
Chengdu New Radiomedicine Technology Co.,Ltd.
听
听
*If Applicable.